Lineage Cell Therapeutics Inc (LCTX): AGEX-iTR1547 On Adis Insight Site Fro...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Lineage Cell Therapeutics Inc (LCTX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	1
Posts	69
Boards Moderated	0
Alias Born	03/31/2018

Re: None

Wednesday, 06/13/2018 9:21:11 AM

Wednesday, June 13, 2018 9:21:11 AM

AGEX-iTR1547 On Adis Insight Site

From Adis Insight
https://adisinsight.springer.com/drugs/800052224

Drug Profile
AGEX iTR1547
Alternative Names: AGEX-iTR1547
Latest Information Update: 12 Jun 2018
Price : $50 *

Buy Profile
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance
Originator
AgeX Therapeutics
Class
Cardiovascular therapies; Cell therapies
Mechanism of Action
Undefined mechanism
Orphan Drug Status
No
New Molecular Entity
Yes
Highest Development Phases
Preclinical
Heart failure
Most Recent Events
31 May 2018
Preclinical trials in Heart failure in USA (unspecified route) before May 2018

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent LCTX News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:26 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/07/2024 10:17:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:27:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:30:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:27:33 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 12:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:58:18 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 11:57:07 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:25:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:20:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:00:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 12:08:49 AM
Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
Take Part in the Next Generation of Spinal Cord Injury Treatments with These Companies • AllPennyStocks.com • 11/16/2023 09:21:00 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 09:19:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:10:32 PM
Small Company Working on Big Breakthrough in Treating Spinal Cord Injuries • AllPennyStocks.com • 10/11/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 09:01:43 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:16:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:10:12 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/27/2023 08:15:41 PM

More LCTX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow